“Hyperthermic vs normothermic mitomycin C for intermediate-risk NMIBC: a real-world retrospective cohort study”, Arch Ital Urol Androl, vol. 97, no. 4, Nov. 2025, doi: 10.4081/aiua.2025.14167.